Global PVA Drugs Market 2014-2018: Key Vendors are Actavis, Novo Nordisk, Pfizer, and Shionogi & Co

News provided by

Research and Markets

21 May, 2014, 12:05 GMT

DUBLIN, May 21, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/78cbh2/global_pva_drugs) has announced the addition of the "Global PVA Drugs Market 2014-2018" report to their offering.

Continue Reading
Research and Markets Logo. (PRNewsFoto/PR NEWSWIRE EUROPE)
Research and Markets Logo. (PRNewsFoto/PR NEWSWIRE EUROPE)

http://photos.prnewswire.com/prnh/20130307/600769

Vaginal atrophy is defined as a decrease in estrogen production. Less estrogen leads to thinning, drying, and decreased elasticity of the vaginal tissues. PVA is defined as the decrease in estrogen after menopause. Up to 40 percent of postmenopausal women have symptoms of atrophic vaginitis. In PVA there are symptoms of redness, burning, itching, dryness, irritation, and dyspareunia. HRT, estrogen creams, and other topical preparations are used in the treatment of PVA.

The analysts forecast the Global PVA Drugs market will grow at a CAGR of 7.1 percent over the period 2013-2018.

The Global PVA Drugs market can be divided into two segments: Topical Estrogen and Systemic Estrogen. To calculate the market size, the report considers the revenue generated from the sales of various drugs (creams, tablets, and rings) used in the treatment of PVA.

The report, the Global PVA Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global PVA Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Competitive Analysis of Marketed Products

08. Pipeline Snapshot

09. Rate of Incidence and Prevalence

10. Market Segmentation by Types

11. Geographical Segmentation

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

20. Key Vendor Analysis

21. Other Reports in this Series

Companies Mentioned:

  • ANI Pharmaceuticals Inc.
  • Actavis plc
  • Bionovo Inc.
  • EndoCeutics Inc.
  • Novo Nordisk A/S
  • PeP-Tonic Medical AB
  • Pfizer Inc.
  • QuatRx Pharmaceutical Co.
  • Shionogi & Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Therapeutics MD Inc.
  • Upsher-Smith Laboratories Inc.

For more information visit http://www.researchandmarkets.com/research/78cbh2/global_pva_drugs

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net